| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |